Rallybio (RLYB) Short Interest Ratio & Short Volume → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free RLYB Stock Alerts $1.86 -0.05 (-2.62%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Rallybio Short Interest DataCurrent Short Volume1,960,000 sharesPrevious Short Volume2,960,000 sharesChange Vs. Previous Month-33.78%Dollar Volume Sold Short$3.76 millionShort Interest Ratio / Days to Cover1.2Last Record DateApril 30, 2024Outstanding Shares41,450,000 sharesFloat Size20,270,000 sharesShort Percent of Float9.67%Today's Trading Volume222,138 sharesAverage Trading Volume1,145,085 sharesToday's Volume Vs. Average19% Short Selling Rallybio ? Sign up to receive the latest short interest report for Rallybio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLYB Short Interest Over TimeRLYB Days to Cover Over TimeRLYB Percentage of Float Shorted Over Time Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. Rallybio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,960,000 shares $3.76 million -33.8%9.7%1.2 $1.92 4/15/20242,960,000 shares $5.42 million +126.0%17.2%1.9 $1.83 3/31/20241,310,000 shares $2.42 million +2.3%7.6%6.2 $1.85 3/15/20241,280,000 shares $2.07 million +6.7%7.4%5.7 $1.62 2/29/20241,200,000 shares $2.79 million +11.1%7.0%5.2 $2.33 2/15/20241,080,000 shares $2.01 million +43.4%6.3%4.8 $1.86 Get the Latest News and Ratings for RLYB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rallybio and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024753,400 shares $1.02 million +1.2%4.4%3.5 $1.35 1/15/2024744,600 shares $1.42 million +9.9%4.3%5.1 $1.91 12/31/2023677,600 shares $1.62 million -62.6%3.9%5.5 $2.39 12/15/20231,810,000 shares $5.50 million -14.6%10.7%16.8 $3.04 11/30/20232,120,000 shares $4.05 million -0.5%12.6%24.7 $1.91 11/15/20232,130,000 shares $4.97 million +0.5%12.6%34.2 $2.34 10/31/20232,120,000 shares $8.90 million +119.3%12.6%49 $4.20 10/15/2023966,800 shares $3.56 million -4.3%5.7%24.6 $3.68 9/30/20231,010,000 shares $3.40 million +1.0%6.0%24.3 $3.37 9/15/20231,000,000 shares $4.93 million No Change5.9%12.9 $4.93 8/31/20231,000,000 shares $5.32 million -4.8%5.9%11.5 $5.32 8/15/20231,050,000 shares $6.29 million -1.9%6.2%10.5 $5.99 7/31/20231,070,000 shares $6.40 million -5.3%6.4%11 $5.98 7/15/20231,130,000 shares $6.16 million +4.6%6.8%11.9 $5.45 6/30/20231,080,000 shares $6.11 million +41.8%6.8%11.4 $5.66 6/15/2023761,900 shares $5.62 million -18.6%4.8%8.3 $7.37 5/31/2023936,300 shares $6.70 million -0.1%5.8%15.7 $7.16 5/15/2023936,800 shares $5.10 million -0.1%5.8%16.8 $5.44 4/30/2023938,100 shares $5.06 million +1.5%5.8%16.5 $5.39 4/15/2023924,000 shares $3.98 million +1.0%5.7%14.4 $4.31 3/31/2023914,800 shares $5.22 million +3.3%5.9%14 $5.71 3/15/2023885,800 shares $4.43 million +11.4%5.7%13.5 $5.00 2/28/2023795,400 shares $6.26 million +0.5%5.2%9.3 $7.87 2/15/2023791,200 shares $5.44 million +8.3%5.3%9.1 $6.87 1/31/2023730,300 shares $5.07 million +2.5%4.8%6.3 $6.94 1/15/2023712,800 shares $4.40 million -7.1%4.5%6 $6.17 12/30/2022767,600 shares $5.04 million -0.3%4.9%6.6 $6.57 12/15/2022769,800 shares $5.40 million +1.0%4.4%6.5 $7.02 11/30/2022762,400 shares $4.39 million +0.6%5.3%7.6 $5.76 11/15/2022757,600 shares $4.42 million -1.1%5.2%8 $5.84 10/31/2022766,200 shares $7.32 million -0.4%6.1%13.5 $9.56 10/15/2022769,200 shares $6.69 million +1.3%6.1%14.3 $8.70 9/30/2022759,400 shares $10.99 million +19.0%6.1%15.3 $14.47 9/15/2022638,300 shares $8.62 million -5.1%5.1%11.3 $13.51“Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. RLYB Short Interest - Frequently Asked Questions What is Rallybio's current short interest? Short interest is the volume of Rallybio shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,960,000 shares of RLYB short. 9.67% of Rallybio's shares are currently sold short. Learn More on Rallybio's current short interest. What is a good short interest ratio for Rallybio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLYB shares currently have a short interest ratio of 1.0. Learn More on Rallybio's short interest ratio. What is a good short interest percentage for Rallybio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.67% of Rallybio's floating shares are currently sold short. Is Rallybio's short interest increasing or decreasing? Rallybio saw a decline in short interest in April. As of April 30th, there was short interest totaling 1,960,000 shares, a decline of 33.8% from the previous total of 2,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Rallybio's float size? Rallybio currently has issued a total of 41,450,000 shares. Some of Rallybio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rallybio currently has a public float of 20,270,000 shares. How does Rallybio's short interest compare to its competitors? 9.67% of Rallybio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Rallybio: Jaguar Health, Inc. (5.19%), Hookipa Pharma Inc (0.91%), Tempest Therapeutics, Inc. (9.42%), Assembly Biosciences, Inc. (0.68%), SCYNEXIS, Inc. (2.58%), vTv Therapeutics Inc. (3.18%), Marinus Pharmaceuticals, Inc. (9.10%), InflaRx (0.22%), SELLAS Life Sciences Group, Inc. (12.10%), Affimed (1.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Rallybio stock? Short selling RLYB is an investing strategy that aims to generate trading profit from Rallybio as its price is falling. RLYB shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rallybio? A short squeeze for Rallybio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLYB, which in turn drives the price of the stock up even further. How often is Rallybio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLYB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: JAGX Short Interest Data HOOK Short Interest Data TPST Short Interest Data ASMB Short Interest Data SCYX Short Interest Data VTVT Short Interest Data MRNS Short Interest Data IFRX Short Interest Data SLS Short Interest Data AFMD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLYB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressHow Biden has already won 2024Porter & Company